Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Segments and Strategic Initiatives
A logo

Agilent Technologies Reports 7% Revenue Growth to $6.95 Billion and Strategic Reorganization

A10-KFiling Date: 12/22/2025
Agilent Technologies, Inc.
Description

What this story covers

Agilent Technologies’ fiscal 2025 10-K reveals a resilient 7% revenue increase to $6.95 billion, fueled by its BIOVECTRA acquisition and strategic reorganization. Despite tariff-driven margin pressures, the company is prioritizing biopharma expansion and operational efficiency for 2026.

Story snapshot

CompanyAgilent Technologies, Inc.
TickerA
VariantStandard detailed
Duration15:55
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0001090872-25-000087
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in